S E McCormack1, M A McCarthy, S G Harrington, L Farilla, M I Hrovat, D M Systrom, B J Thomas, M Torriani, K McInnis, S K Grinspoon, A Fleischman. 1. Program in Nutritional Metabolism and Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA; Division of Endocrinology, Children's Hospital Boston and Harvard Medical School, Boston, Massachusetts, USA; Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Abstract
BACKGROUND: Obesity is associated with poor fitness and adverse metabolic consequences in children. OBJECTIVE: To investigate how exercise and lifestyle modification may improve fitness and insulin sensitivity in this population. DESIGN AND SUBJECTS: Randomized controlled trial, 21 obese (body mass index ≥ 95% percentile) subjects, ages 10 to 17 years. METHODS: Subjects were given standardized healthful lifestyle advice for 8 weeks. In addition, they were randomized to an in-home supervised exercise intervention (n = 10) or control group (n = 11). MEASUREMENTS: Fasting laboratory studies (insulin, glucose, lipid profile) and assessments of fitness, body composition, skeletal muscle oxidative phosphorylation and intramyocellular lipid content (IMCL), were performed at baseline and study completion. RESULTS:Subjects were 13.0 ± 1.9 (standard deviation) years old, 72% female and 44% non-white. Exercise improved fitness (P = 0.03) and power (P = 0.01), and increased IMCL (P = 0.02). HOMA-IR decreased among all subjects in response to lifestyle modification advice (P = 0.01), regardless of exercise training assignment. In univariate analysis in all subjects, change in cardiovascular fitness was associated with change in HOMA-IR. In exploratory analyses, increased IMCL was associated with greater resting energy expenditure (r = 0.78, P = 0.005) and a decrease in fasting respiratory quotient (r = -0.70, P = 0.02) (n = 11). CONCLUSIONS: Change in fitness was found to be related to change in insulin resistance in response to lifestyle modification and exercise in obese children. IMCL increased with exercise in these obese children, which may reflect greater muscle lipid oxidative capacity.
RCT Entities:
BACKGROUND:Obesity is associated with poor fitness and adverse metabolic consequences in children. OBJECTIVE: To investigate how exercise and lifestyle modification may improve fitness and insulin sensitivity in this population. DESIGN AND SUBJECTS: Randomized controlled trial, 21 obese (body mass index ≥ 95% percentile) subjects, ages 10 to 17 years. METHODS: Subjects were given standardized healthful lifestyle advice for 8 weeks. In addition, they were randomized to an in-home supervised exercise intervention (n = 10) or control group (n = 11). MEASUREMENTS: Fasting laboratory studies (insulin, glucose, lipid profile) and assessments of fitness, body composition, skeletal muscle oxidative phosphorylation and intramyocellular lipid content (IMCL), were performed at baseline and study completion. RESULTS: Subjects were 13.0 ± 1.9 (standard deviation) years old, 72% female and 44% non-white. Exercise improved fitness (P = 0.03) and power (P = 0.01), and increased IMCL (P = 0.02). HOMA-IR decreased among all subjects in response to lifestyle modification advice (P = 0.01), regardless of exercise training assignment. In univariate analysis in all subjects, change in cardiovascular fitness was associated with change in HOMA-IR. In exploratory analyses, increased IMCL was associated with greater resting energy expenditure (r = 0.78, P = 0.005) and a decrease in fasting respiratory quotient (r = -0.70, P = 0.02) (n = 11). CONCLUSIONS: Change in fitness was found to be related to change in insulin resistance in response to lifestyle modification and exercise in obesechildren. IMCL increased with exercise in these obesechildren, which may reflect greater muscle lipid oxidative capacity.
Authors: V B Schrauwen-Hinderling; P Schrauwen; M K C Hesselink; J M A van Engelshoven; K Nicolay; W H M Saris; A G H Kessels; M E Kooi Journal: J Clin Endocrinol Metab Date: 2003-04 Impact factor: 5.958
Authors: E Bonora; G Targher; M Alberiche; R C Bonadonna; F Saggiani; M B Zenere; T Monauni; M Muggeo Journal: Diabetes Care Date: 2000-01 Impact factor: 19.112
Authors: Catherine L Davis; Norman K Pollock; Jennifer L Waller; Jerry D Allison; B Adam Dennis; Reda Bassali; Agustín Meléndez; Colleen A Boyle; Barbara A Gower Journal: JAMA Date: 2012-09-19 Impact factor: 56.272
Authors: Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson Journal: Vital Health Stat 11 Date: 2002-05
Authors: Ram Weiss; Sylvie Dufour; Sara E Taksali; William V Tamborlane; Kitt F Petersen; Riccardo C Bonadonna; Linda Boselli; Gina Barbetta; Karin Allen; Francis Rife; Mary Savoye; James Dziura; Robert Sherwin; Gerald I Shulman; Sonia Caprio Journal: Lancet Date: 2003-09-20 Impact factor: 79.321
Authors: Terry T K Huang; Katarzyna E Wyka; Emily B Ferris; Jennifer Gardner; Kelly R Evenson; Devanshi Tripathi; Gabriel Martinez Soto; Matthew S Cato; Jon Moon; Julia Wagner; Joan M Dorn; Diane J Catellier; Lorna E Thorpe Journal: BMC Public Health Date: 2016-11-14 Impact factor: 3.295
Authors: Yftach Gepner; Ilan Shelef; Dan Schwarzfuchs; Noa Cohen; Nitzan Bril; Michal Rein; Gal Tsaban; Hila Zelicha; Anat Yaskolka Meir; Lilac Tene; Benjamin Sarusy; Philip Rosen; Jay R Hoffman; Jeffrey R Stout; Joachim Thiery; Uta Ceglarek; Michael Stumvoll; Matthias Blüher; Meir J Stampfer; Iris Shai Journal: PLoS One Date: 2017-11-30 Impact factor: 3.240
Authors: Ernst Mayerhofer; Franz Ratzinger; Nina Elvira Kienreich; Annika Stiel; Nadine Witzeneder; Eva Schrefl; Georg Greiner; Christoph Wegscheider; Irene Graf; Klaus Schmetterer; Rodrig Marculescu; Thomas Szekeres; Thomas Perkmann; Martina Fondi; Oswald Wagner; Harald Esterbauer; Matthias Mayerhofer; Stefana Holocher-Ertl; Claudia Wojnarowski; Gregor Hoermann Journal: Front Pediatr Date: 2020-02-21 Impact factor: 3.418